tradingkey.logo
tradingkey.logo

Medline dips as PE backers trim stakes in $3.1 bln stock sale

ReutersMar 5, 2026 12:55 PM

Medline's MDLN.O shares down 1.9% premarket at $42.08 as ~$3.1 bln secondary offering priced just months after medical supplier's Dec public debut

MDLN late Weds announced sale of 75 mln shares by Blackstone BX.N, Carlyle CG.O, Hellman & Friedman (H&F) and Abu Dhabi Investment Authority (ADIA) at $41

Offering price represents 4.4% discount to stock's last close of $42.88

MDLN's stock closed at $45.85 on Mon, prior to offering launch early Tues, having surged 58% since co's $7.2 bln IPO (inclusive of full overallotment), 2025's largest

Private equity backers BX, CG and H&F offloaded 23.3 mln shares each, ADIA sold 5.1 mln shares, per the offering prospectus

Northfield, Illinois-based MDLN has ~1.3 bln shares outstanding

Goldman Sachs, Morgan Stanley, BofA and JP Morgan global coordinators and joint bookrunners for offering

20 of 25 analysts rate the stock "strong buy" or "buy", rest "hold"; median PT $55, per latest LSEG data

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Recommended Articles

Tradingkey
KeyAI